Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite. As a result it also acts as an α2-adrenergic receptor antagonist to an extent.
This page contains content from the copyrighted Wikipedia article "Revospirone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
